Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXFP1 | Q9HBX9 | 7/20 | 0.84 |
| ▸ | HTR6 | P50406 | 12/20 | 0.81 |
| ▸ | MAPT | P10636 | 4/20 | 0.61 |
| ▸ | TP53 | P04637 | 1/20 | 0.60 |
| ▸ | POLB | P06746 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8016806 | 0.91 | RXFP1 (1.00) | RXFP1HTR6MAPTTP53POLB | |
| SCHEMBL8028821 | 0.89 | HTR6 (1.00) | RXFP1HTR6MAPTTP53POLB | |
| SCHEMBL8028237 | 0.89 | HTR6 (0.85) | RXFP1HTR6MAPTTP53POLB | |
| SCHEMBL8034015 | 0.88 | HTR6 (1.00) | RXFP1HTR6MAPTTP53POLB | |
| SCHEMBL8027276 | 0.85 | RXFP1 (0.79) | RXFP1HTR6MAPTTP53POLB | |
| SCHEMBL8018164 | 0.82 | HTR6 (0.83) | RXFP1HTR6MAPTTP53POLB | |
| SCHEMBL8028840 | 0.80 | RXFP1 (0.75) | RXFP1HTR6MAPTTP53 | |
| SCHEMBL8027731 | 0.76 | HTR6 (1.00) | RXFP1HTR6MAPTTP53POLB | |
| SCHEMBL8019071 | 0.75 | HTR6 (0.76) | RXFP1HTR6MAPTPOLB | |
| SCHEMBL15285384 | 0.75 | HTR6 (0.84) | RXFP1HTR6MAPTTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009093934-A2 | SUBSTITUTED 3-SULPHONYL-[1,2,3]TRIAZOLO [1,5-A]PYRIMIDINES-ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS, MEDICINAL SUBSTANCE, PHARMACEUTICAL COMPOSITION, MEDICINAL PREPARATION AND METHODS FOR THE PRODUCTION THEREOF | ALLA CHEM, LLC (US) | 2009-07-30 | — | — | WO | disclosed |